A CRO Laboratory with a Global Presence
For Expertise Where You Need It

We are expanding our presence worldwide to better serve our clients and to support global clinical trials. All our locations are dedicated to quality science and strong regulatory compliance. Our platforms and systems are standardized globally and follow well-defined processes to safeguard your data. In addition to our commitment to superior sample management, you can count on our local scientific teams at every site for guidance on assay development and sample processing.

More

Discussions on COVID-19 immune responses, including responses in early vaccine clinical studies, have focused largely on antibody responses. However, recent data indicate that the cellular immune response also plays an important role and should be considered when evaluating the immune response. Assessing T-cell responses can provide critical information about vaccine responses and the development and persistence of protective immunity against SARS-CoV-2 that will be critical in the fight against COVID-19.

Join Scott Gottlieb, MD, 23rd Commissioner of the FDA, and James E. Rothman, PhD, Nobel Laureate, both members of Caprion-HistoGeneX’s scientific advisory board, as well as Eustache Paramithiotis, PhD, our VP of Research & Development, who, during this webinar, will help you recognize the importance of cell immunity in COVID-19-related vaccine development.

More

China is ready for Flow Cytometry and IHC!

It's appropriate to begin this newsletter with a "thank you." We are grateful for your encouragement and support for our endeavor in Jining, China. Our laboratory is operational for IHC and flow cytometry. Both IHC and flow cytometry clinical trial patient specimens arrive this month. Our highly experienced Chinese team is in place and we have completed numerous process milestones (e.g. HGRAC, Biosafety level 2 certification, import permits, etc.). For your Chinese clinical trial projects, you will enjoy the seamless workflow from proposal generation to data reporting supported by our local Chinese team. Thank you for committing your clinical trials into our hands. We are honored to have your trust and enthusiasm.

More

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development.

Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer global, integrated services to support discovery and development of vaccines and antiviral therapies.

More

Operationally, our Jining histopathology laboratory section is coming together nicely. Despite the challenges presented by COVID-19 measures, we have been able to meet target timelines and remain on schedule. We have retained a full laboratory team who are English speakers and have pharma biomarker service experience.

More

Now that our Jining team is back in the lab, equipment installation is ongoing and is on track to receive samples next month. In our IHC department, we currently have:

  • two (2) qualified and validated BenchMark ULTRAs,
  • one (1) DISCOVERY ULTRA,
  • a Tissue-Tek Prisma® Plus Automated Slide Stainer,
  • and a Tissue-Tek Film® Coverslipper from Sakura®.

Our digital pathology department is validating the 3D HISTECH Pannoramic 250 Flash III Scanner.

More

On March 30, our Chinese team returned back to the building to resume their set-up of our facility in Jining, China. This is a very meaningful date for us, our first laboratory in our global network to return to non-quarantine working condition. Parts of China, e.g., the city of Beijing, remain under quarantine guidelines. Our Beijing employees who are in Jining face a 2-week quarantine if they decide to return home to Beijing. We are grateful for their willingness to resume operations and we have provided accommodations for them. Our laboratory will be ready to receive specimens for IHC and flow cytometry testing in June.

More